Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01621932 · ClinicalTrials.gov registry record · NA

Anterior Capsulectomy vs. Repair in Direct Anterior THA

A NA study of Total Hip Arthroplasty, sponsored by OrthoCarolina Research Institute.

Completed
Registry status
NA
Development phase
82
Enrollment target
1
Study location

NCT01621932: Completed NA study of Total Hip Arthroplasty, sponsored by OrthoCarolina Research Institute.

NCT01621932 is a NA study of Total Hip Arthroplasty that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 82 participants, below the 138-participant average among 12 other Total Hip Arthroplasty trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01621932, a NA study of Total Hip Arthroplasty, has completed, sponsored by OrthoCarolina Research Institute.

COMPLETED
Registry status
NA
Development phase
82 participants
Enrollment target
1
Study location

Study Summary

Randomized prospective study comparing the anterior capsule repair vs capsulectomy with regards to post-operative pain and range of motion outcomes in elective primary unilateral direct anterior approach THA for osteoarthritis. Visual Analog Scores (VAS) will be recorded for preoperative and postoperative months 1 and 4. Hip range of motion will be assessed by goniometer measurements and lateral hip radiographs in maximum flexion. The purpose of the study is to compare post-operative pain control and hip range of motion between two surgical techniques (anterior capsular repair vs. anterior capsulectomy) during direct anterior total hip arthroplasty.

Conditions Studied

Interventions

  • PROCEDURE Direct anterior approach with capsulectomy
  • PROCEDURE Direct anterior approach without capsulectomy

Study Locations (1)

North Carolina

  • OrthoCarolina, P.A. - Charlotte

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2012-03-01
Est. Completion 2017-08-02
Phase NA
OrthoCarolina Research Institute

28 total trials

What the finished NCT01621932 record still lists

NCT01621932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 138-participant average among 12 other Total Hip Arthroplasty trials with a reported enrollment target (41% lower).

The record links to 1 condition, with Total Hip Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Direct anterior approach with capsulectomy is the first listed.

NCT01621932 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01621932 about?

NCT01621932 is a clinical study titled "Anterior Capsulectomy vs. Repair in Direct Anterior THA". Randomized prospective study comparing the anterior capsule repair vs capsulectomy with regards to post-operative pain and range of motion outcomes in elective primary unilateral direct anterior approach THA for osteoarthritis. Visual Analog Scores (VAS) will be recorded for preoperative and postope...

What is the current status of trial NCT01621932?

This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2012-03-01. Estimated completion is 2017-08-02.

What conditions does trial NCT01621932 study?

This clinical trial studies the following conditions: Total Hip Arthroplasty.

What interventions are being tested in trial NCT01621932?

The interventions under investigation include: Direct anterior approach with capsulectomy (PROCEDURE), Direct anterior approach without capsulectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01621932?

This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01621932 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Hip Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01621932's enrollment target sits among peer trials

82 8th of 12 higher than 5 of 12 other Total Hip Arthroplasty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Total Hip Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03319901 · 82 participants · Phase 1

    Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

  • NCT03493425 · 82 participants · Phase 2

    Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

  • NCT04105270 · 82 participants · Phase 2

    RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

  • NCT04428658 · 82 participants · NA

    Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01621932, the US trial registry maintained by the National Library of Medicine. NCT01621932 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.